Keyphrases
Agent Group
9%
Alitretinoin
45%
Allergen
45%
Allergic Contact Dermatitis
18%
Benzophenone-3 (BP-3)
18%
Bleeding
45%
Blister
45%
British Association
9%
Butyl Methoxydibenzoylmethane
9%
Causal Factors
90%
Causative Agents
45%
Chronic Conditions
45%
Chronic Eczema
90%
Chronic Use
45%
Clinical Trials
45%
Current Treatment
45%
Dermatosis
45%
Endogenous Factors
45%
Etiology
45%
Etofenamate
9%
Europe
9%
Functional Disability
45%
Hand Dermatitis
45%
Hand Eczema
90%
Irritant
90%
Itch
45%
Ketoprofen
18%
Limited Treatment Options
45%
Low Self-esteem
45%
Manual Dexterity
45%
Mild Cases
45%
New Therapies
45%
Number of Patients
45%
Occupational Disability
45%
Octocrylene
18%
Organic Sunscreen
9%
Organic Ultraviolet Absorbers
27%
Photoallergic Contact Dermatitis
90%
Photoinhibition
9%
Photopatch Test
90%
Poor Prognosis
45%
Psychological Disability
45%
Relative Frequency
9%
Sick Leave
45%
Social Disability
45%
Social Phobia
45%
Topical Corticosteroids
90%
Topical Nonsteroidal Anti-inflammatory Drugs
27%
Treatment Options
45%
Unemployment Anxiety
45%
Medicine and Dentistry
Alitretinoin
45%
Allergen
45%
Avobenzone
9%
Blister
45%
Clinical Trial
45%
Contact Dermatitis
90%
Dermatitis
45%
Dermatosis
45%
Diseases
45%
Eczema
90%
Emollient Agent
45%
Etofenamate
9%
Hand Eczema
90%
Irritant Agent
100%
Ketoprofen
18%
Nonsteroid Antiinflammatory Agent
27%
Octocrylene
18%
Oxybenzone
18%
Photoinhibition
9%
Photopatch Test
90%
Self Esteem
45%
Skin Allergy
18%
Social Phobia
45%
Sunscreen
18%
Topical Corticosteroid
90%
Pharmacology, Toxicology and Pharmaceutical Science
Alitretinoin
45%
Allergen
45%
Avobenzone
9%
Blister
45%
Clinical Trial
45%
Contact Dermatitis
90%
Dermatitis
45%
Disease
45%
Eczema
90%
Emollient Agent
45%
Etofenamate
9%
Hand Eczema
90%
Irritant Agent
100%
Ketoprofen
18%
Non-Steroidal Anti-Inflammatory Drug
27%
Octocrylene
18%
Oxybenzone
18%
Skin Allergy
18%
Skin Disease
45%
Social Phobia
45%
Sunscreen
18%
Topical Corticosteroid
90%